Sionna Therapeutics, Inc. (SION)
42.73
-0.81
(-1.86%)
USD |
NASDAQ |
Apr 20, 16:00
42.73
0.00 (0.00%)
After-Hours: 20:00
Sionna Therapeutics Shareholders Equity (Quarterly) : 306.83M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| UroGen Pharma Ltd. | -105.47M |
| Cogent Biosciences, Inc. | 636.37M |
| Terns Pharmaceuticals, Inc. | 1.007B |
| Edgewise Therapeutics, Inc. | 522.26M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.93M |
| Total Liabilities (Quarterly) | 21.10M |
| Debt to Equity Ratio | 0.0283 |
| Current Ratio | 20.61 |
| Net Debt Paydown Yield | 0.01% |